6AUGUST - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comTechnology is key to innovation in pharmacovigilance. The rapid rise in disease occurrence has led to an immense increase in drug development and consumption. And technology proves to be the mainstay in pharmacovigilance, allowing better, faster, and efficient drug analysis both before and after the release of every drug. With patient-centricity as an emerging theme, safety data monitoring has become key, and pharmacovigilance is continuously evolving to meet these demands. Incorporating modern technologies enable the pharmacovigilance systems to advance and aid in conducting more efficient processes aligned with the latest regulatory expectations. More companies in the pharmacovigilance market are looking towards implementing artificial intelligence in safety data management and analytics to increase efficiency and accuracy with increasing case volumes. Innovative automation tools and processes prove crucial to pharmacovigilance strategies for managing the safety of pharmaceutical products. Automation will streamline end-to-end safety processes and reduce redundant steps while increasing human labor efficiency. Cloud-based solutions, services and mobile applications will further optimize the processes and allow better data intake, storage, and analysis, and even provide regional and temporal insights into adverse drug reaction patterns. Further, they will also enable timely reporting and analysis, leading to prompt regulatory decision making.Along the tech timeline, the tech wave in pharmacovigilance is bringing forth compelling innovations to boost efficiency. On this note, we present to you this edition on pharmacovigilance with exclusive coverage on leading-edge services and thought leadership from subject-matter experts on the latest trends impacting the pharmacovigilance arena. Leafing through these pages will give you comprehensive insights on how the pharmacovigilance function has embraced varied technologies to positively impact its central role of drug safety.Let us know your thoughts!The Changing Facets of PharmacovigilanceCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.AUGUST - 03 - 2020, Vol 06 - Issue 15 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >